A new paradigm of Clinical Research: Decentralized Clinical Trials - Chemistry Today (publication of 30.08.2022)

Site-based clinical trials have been the gold standard of clinical research: study partecipants are recruited and enrolled in heathcare setting, and are required to attend study sites on a regular basis for in-person visits with the study doctor.

Nonetheless, this approach has been shown to be costly, slow and often inefficient, as well as burdensome for participants and caregivers due to travel and other logistical demands. indeed, one major cause of trial failure is the inability to enrol and retain a sufficient number of perticipants.

Trial decentralization is gaining momentum as one way to improve clinical trials. Decentralized clinical trials (DCTs) are aimed at making studies centred around participants' homes or local surroundings.

This article illustrates the key features and advantages of DCTs, as well as the mail challenges to be tackled to foster the successful implementation of this novel paradigm of clinical research.

Click here for the full article.


Author: Eleonora Comi, PRINEOS Medical Manager

Source: Chemistry Today Vol. 40(4), July/August 2022